BridgeBio Oncology Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Oncology Therapeutics, Inc. has filed 170 SEC EDGAR filings since 20 Dec 2023

SEC filing history

Showing 26-50 of 170 matching filings.

Per page
25
Current page
2
3

3

Filing date
30 Apr 2026
Reporting date
21 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Apr 2026
Reporting date
20 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
29 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41955

ARS

Filing date
28 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41955

DEFA14A

Filing date
28 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41955

DEF 14A

Filing date
28 Apr 2026
Reporting date
16 Jun 2026
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Mar 2026
Reporting date
24 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
26 Mar 2026
Reporting date
24 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2026
Reporting date
10 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2026
Reporting date
10 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Mar 2026
Reporting date
10 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
06 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
07 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
07 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .